These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 2299628)

  • 1. Synthesis and cardiac electrophysiological activity of aryl-substituted derivatives of the class III antiarrhythmic agent sematilide. Potential class I/III agents.
    Phillips GB; Morgan TK; Nickisch K; Lind JM; Gomez RP; Wohl RA; Argentieri TM; Sullivan ME
    J Med Chem; 1990 Feb; 33(2):627-33. PubMed ID: 2299628
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthesis, cardiac electrophysiology, and beta-blocking activity of novel arylpiperazines with potential as class II/III antiarrhythmic agents.
    Phillips GB; Morgan TK; Lumma WC; Gomez RP; Lind JM; Lis R; Argentieri T; Sullivan ME
    J Med Chem; 1992 Feb; 35(4):743-50. PubMed ID: 1347318
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antiarrhythmic and proarrhythmic effects of sematilide in canine ventricular arrhythmia models.
    Xue YX; Eto K; Akie Y; Hashimoto K
    Jpn J Pharmacol; 1996 Feb; 70(2):129-38. PubMed ID: 8866750
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of sematilide, a novel class III antiarrhythmic agent, on action potential in guinea pig atrium.
    Ishii Y; Muraki K; Kurihara A; Imaizumi Y; Watanabe M
    Jpn J Pharmacol; 1995 Jun; 68(2):175-82. PubMed ID: 7563974
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Correlation of the electrophysiological and antiarrhythmic properties of the N-acetyl metabolite of procainamide with plasma and tissue drug concentrations in the dog.
    Bagwell EE; Walle T; Drayer DE; Reidenbert MM; Pruett JK
    J Pharmacol Exp Ther; 1976 Apr; 197(1):38-48. PubMed ID: 1263131
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis and cardiac electrophysiological activity of N-substituted-4-(1H-imidazol-1-yl)benzamides--new selective class III agents.
    Morgan TK; Lis R; Lumma WC; Nickisch K; Wohl RA; Phillips GB; Gomez RP; Lampe JW; Di Meo SV; Marisca AJ
    J Med Chem; 1990 Apr; 33(4):1091-7. PubMed ID: 2319557
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis of novel (aryloxy)propanolamines and related compounds possessing both class II and class III antiarrhythmic activity.
    Lis R; Morgan TK; Marisca AJ; Gomez RP; Lind JM; Davey DD; Phillips GB; Sullivan ME
    J Med Chem; 1990 Oct; 33(10):2883-91. PubMed ID: 1976812
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Electrophysiologic and antiarrhythmic activities of 4-amino-N-[2-(diethylamino)ethyl]-3,5-dimethylbenzamide, a sterically hindered procainamide analogue.
    Robertson DW; Beedle EE; Wilson H; Parli CJ; Smallwood JK; Steinberg MI
    J Med Chem; 1988 Jul; 31(7):1290-5. PubMed ID: 3385724
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cellular electrophysiological effects of the class III antiarrhythmic agents sematilide and clofilium on rabbit atrial tissues.
    Argentieri TM; Carroll MS; Sullivan ME
    J Cardiovasc Pharmacol; 1991 Jul; 18(1):167-74. PubMed ID: 1719286
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Heterocyclic analogues of benzamide antiarrhythmic agents.
    Hanna RG; Lampe JW; Lumma WC; Erhardt PW; Wong SS; Sullivan ME
    J Med Chem; 1989 Mar; 32(3):688-93. PubMed ID: 2918518
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthesis and antiarrhythmic activity of novel 3-alkyl-1-[omega-[4-[(alkylsulfonyl)amino]phenyl]-omega- hydroxyalkyl]-1H-imidazolium salts and related compounds. 2.
    Lis R; Davey DD; Morgan TK; Lumma WC; Wohl RA; Jain VK; Wan CN; Argentieri TM; Sullivan ME; Cantor EH
    J Med Chem; 1987 Dec; 30(12):2303-9. PubMed ID: 3681900
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Selective class III antiarrhythmic agents. 1 Bis(arylalkyl)amines.
    Cross PE; Arrowsmith JE; Thomas GN; Gwilt M; Burges RA; Higgins AJ
    J Med Chem; 1990 Apr; 33(4):1151-5. PubMed ID: 2319561
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antiarrhythmic plasma concentrations of NIK-244 on canine ventricular arrhythmias.
    Hashimoto K; Matsuzaki T; Haruno A
    J Cardiovasc Pharmacol; 1989 Dec; 14(6):892-8. PubMed ID: 2481779
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Broad sensitivity of rodent arrhythmia models to class I, II, III, and IV antiarrhythmic agents.
    Brooks RR; Miller KE; Carpenter JF; Jones SM
    Proc Soc Exp Biol Med; 1989 Jun; 191(2):201-9. PubMed ID: 2726785
    [TBL] [Abstract][Full Text] [Related]  

  • 15. New aminocarboxamides with class III anti-arrhythmic activity.
    Poppe H; Schindler R; Sauer W; Marx D; Bartsch R; Kaverina NV; Lichoscherstow AM; Sokolov SF; Lyskovtsev VV; Seredenin SB; Borisenko SA
    Arch Pharm (Weinheim); 1999 Jul; 332(7):233-42. PubMed ID: 10450168
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis and antiarrhythmic activity of 5,11-dihydro[1]benzoxepino[3,4-b]pyridines.
    Kumazawa T; Harakawa H; Obase H; Oiji Y; Nito M; Kubo K; Ishii A; Tomioka S; Yamada Y
    J Med Chem; 1990 Nov; 33(11):3095-100. PubMed ID: 2231611
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthesis and biological action of the aminotetrahydroisoquinocarbazoles and related compounds: a new class of compounds with antiarrhythmic activity.
    Shimoji Y; Tomita K; Hashimoto T; Saito F; Morisawa Y; Mizuno H; Yorikane R; Koike H
    J Med Chem; 1992 Mar; 35(5):816-22. PubMed ID: 1548673
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthesis and selective class III antiarrhythmic activity of novel N-heteroaralkyl-substituted 1-(aryloxy)-2-propanolamine and related propylamine derivatives.
    Butera JA; Spinelli W; Anantharaman V; Marcopulos N; Parsons RW; Moubarak IF; Cullinan C; Bagli JF
    J Med Chem; 1991 Nov; 34(11):3212-28. PubMed ID: 1956040
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy of the antidepressant iprindole against experimental arrhythmias.
    Colatsky TJ; McCallum JD; Nocella K; Jurkiewicz NK; Bird LB
    Eur J Pharmacol; 1986 Jul; 126(1-2):37-45. PubMed ID: 3758165
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vivo and in vitro antiarrhythmic and arrhythmogenic effects of N-acetyl procainamide.
    Dangman KH; Hoffman BF
    J Pharmacol Exp Ther; 1981 Jun; 217(3):851-62. PubMed ID: 6164783
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.